Sygnis SA (WSE:SYG)
Poland · Delayed Price · Currency is PLN 1.535
-0.040 (-2.54%)
At close: Apr 16, 2026
Sygnis Market Cap
Sygnis has a market cap or net worth of 42.1 million as of April 16, 2026. Its market cap has increased by 109.53% in one year.
Market Cap
42.10M
Enterprise Value
45.08M
Revenue
11.34M
Ranking
n/a
PE Ratio
16.46
Stock Price
1.54
Market Cap Chart
Since March 16, 2012, Sygnis's market cap has increased from 6.21M to 42.10M, an increase of 578.08%. That is a compound annual growth rate of 14.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 42.10M | -28.94% |
| Dec 30, 2025 | 59.24M | 501.78% |
| Dec 30, 2024 | 9.84M | -56.47% |
| Dec 29, 2023 | 22.62M | -56.95% |
| Dec 30, 2022 | 52.54M | 10.53% |
| Dec 30, 2021 | 47.53M | 177.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.01B |
| NEUCA | 3.20B |
| Synektik Spólka Akcyjna | 2.57B |
| Celon Pharma | 1.14B |
| Urteste | 64.84M |
| Read-Gene | 62.72M |
| BioMaxima | 49.23M |
| Pharmena | 37.09M |